BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30096813)

  • 1. CEP55 Promotes Cell Motility via JAK2⁻STAT3⁻MMPs Cascade in Hepatocellular Carcinoma.
    Li M; Gao J; Li D; Yin Y
    Cells; 2018 Aug; 7(8):. PubMed ID: 30096813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEP55: Implications for Immunotherapy and Survival in Hepatocellular Carcinoma.
    Wang Y; Zhang L; Tian J; Luo B; Yao J; Yang Y
    Comb Chem High Throughput Screen; 2024 Jun; ():. PubMed ID: 38847172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic hub gene CBX2 drives a cancer stem cell-like phenotype in HCC revealed by multi-omics and multi-cohorts.
    Meng Q; Zhou Q; Chen X; Chen J
    Aging (Albany NY); 2023 Nov; 15(22):12817-12851. PubMed ID: 37980163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer.
    Xie X; Liang H; Jiangting W; Wang Y; Ma X; Tan Z; Cheng L; Luo Z; Wang T
    Front Mol Biosci; 2023; 10():1198557. PubMed ID: 37484531
    [No Abstract]   [Full Text] [Related]  

  • 5. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1.
    Huang W; Chen Z; Shang X; Tian D; Wang D; Wu K; Fan D; Xia L
    Hepatology; 2015 Jun; 61(6):1920-33. PubMed ID: 25704764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEP55 promotes cell proliferation and inhibits apoptosis via the PI3K/Akt/p21 signaling pathway in human glioma U251 cells.
    Li F; Jin D; Tang C; Gao D
    Oncol Lett; 2018 Apr; 15(4):4789-4796. PubMed ID: 29552118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.
    Wu X; Chen H; Gao Q; Bai J; Wang X; Zhou J; Qiu S; Xu Y; Shi Y; Wang X; Zhou J; Fan J
    Mol Carcinog; 2014 Apr; 53(4):325-36. PubMed ID: 23169062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEP55, serving as a diagnostic marker gene for osteosarcoma, triggers the JAK2-STAT3-MMPs axis.
    Yan Y; He J; Cheng W
    Ann Med Surg (Lond); 2024 Jan; 86(1):190-198. PubMed ID: 38222763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling.
    Xie B; Zen Q; Wang X; He X; Xie Y; Zhang Z; Li H
    Int J Oncol; 2015 May; 46(5):2057-66. PubMed ID: 25738261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RUNX2 promotes hepatocellular carcinoma cell migration and invasion by upregulating MMP9 expression.
    Wang Q; Yu W; Huang T; Zhu Y; Huang C
    Oncol Rep; 2016 Nov; 36(5):2777-2784. PubMed ID: 27666365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1.
    Xie B; Lin W; Ye J; Wang X; Zhang B; Xiong S; Li H; Tan G
    J Exp Clin Cancer Res; 2015 Sep; 34(1):101. PubMed ID: 26362312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking as an Independent Risk Factor for Hepatocellular Carcinoma Due to the α7-Nachr Modulating the JAK2/STAT3 Signaling Axis.
    Li CL; Lin YK; Chen HA; Huang CY; Huang MT; Chang YJ
    J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31492006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 regulates the migration and invasion of a stem‑like subpopulation through microRNA‑21 and multiple targets in hepatocellular carcinoma.
    Zhang N; Duan WD; Leng JJ; Zhou L; Wang X; Xu YZ; Wang XD; Zhang AQ; Dong JH
    Oncol Rep; 2015 Mar; 33(3):1493-8. PubMed ID: 25571964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinoma.
    Su F; Zhao J; Qin S; Wang R; Li Y; Wang Q; Tan Y; Jin H; Zhu F; Ou Y; Cheng Z; Su W; Zhao F; Yang Y; Zhou Z; Zheng J; Li Y; Li Z; Wu Q
    Oncotarget; 2017 Apr; 8(14):23277-23288. PubMed ID: 28177895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma.
    Zhang C; Li C; Chen X; Zhou Y; Yin B; Ni R; Zhang Y; Liu J
    Clin Transl Oncol; 2017 Dec; 19(12):1507-1517. PubMed ID: 28589433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway.
    Luo Q; Wang C; Jin G; Gu D; Wang N; Song J; Jin H; Hu F; Zhang Y; Ge T; Huo X; Chu W; Shu H; Fang J; Yao M; Gu J; Cong W; Qin W
    Carcinogenesis; 2015 Oct; 36(10):1201-12. PubMed ID: 26249360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3/Girdin/Akt activity.
    Ke Y; Bao T; Wu X; Tang H; Wang Y; Ge J; Fu B; Meng X; Chen L; Zhang C; Tan Y; Chen H; Guo Z; Ni F; Lei X; Shi Z; Wei D; Wang L
    Biochem Biophys Res Commun; 2017 Jan; 483(1):509-515. PubMed ID: 27998773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
    Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
    Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.